Is Adjuvant 5-FU-Based Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma Beneficial? A Meta-analysis of an Unanswered Question

Journal of Gastrointestinal Surgery

Volumn 10, Issue 5, 2006, Pages 689-697

  Khanna, Amit ^a   Walker, Gail R ^a   Livingstone, Alan S ^a   Arheart, Kristopher L ^a   Rocha Lima, Caio ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

adjuvant; meta analysis; neoadjuvant; Pancreatic cancer; prospective randomized

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CARCINOMA; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL; HUMAN; META ANALYSIS; PANCREAS TUMOR; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; FLUOROURACIL; HUMANS; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33646687064     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.11.006     Document Type: Article

References (28)

1. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
2. Richter A., Niedergethmann M., Sturm J.W., Lorenz D., Post S., and Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27 (2003) 324-329
3. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group. Ann Surg 189 (1979) 205-208
4. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 59 (1987) 2006-2010
5. Chu Q.D., Khushalani N., Javle M.M., Douglass Jr. H.O., and Gibbs J.F. Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas?. Ann Surg Oncol 10 (2003) 539-545
6. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
7. Abrams R.A. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?. Int J Radiat Oncol Biol Phys 56 (2003) 3-9
8. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
9. Yeo C.J., Abrams R.A., Grochow L.B., et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225 (1997) 621-633
10. Beger H.G., Rau B., Gansauge F., Poch B., and Link K.H. Treatment of pancreatic cancer: Challenge of the facts. World J Surg 27 (2003) 1075-1084
11. Pasetto L.M., Jirillo A., Stefani M., and Monfardini S. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?. Anticancer Res 23 (2003) 2805-2813
12. Penberthy D.R., Rich T.A., and Adams R.B. Postoperative adjuvant therapy for pancreatic cancer. Semin Surg Oncol 21 (2003) 256-260
13. Martenson J.A., Vigliotti A.P., Pitot H.C., et al. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1305-1310
14. Van Laethem J.L., Demols A., Gay F., et al. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: A phase II study. Int J Radiat Oncol Biol Phys 56 (2003) 974-980
15. Moher D., Cook D., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Onkologie 23 (2000) 597-602
16. Klein J.P., and Moeschberger M.L. Survival Analysis: Techniques for Consored and Truncated Data (1997), Springer - Verlag New York, New York
17. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782
18. Collett D. Modeling Survival Data in Medical Research (1994), Chapman and Hall, London
19. Petitti D.B. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine, 2nd ed vol. 7.5.2.1 (2000), Oxford, New York
20. Whittington R., Bryer M.P., Haller D.G., Solin L.J., and Rosato E.F. Adjuvant therapy of resected adenocarcinoma of the pancreas. In J Radiat Oncol Biol Phys 21 (1991) 1137-1143
21. Foo M.L., Gunderson L.L., Nagorney D.M., et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 26 (1993) 483-489
22. Spitz F.R., abbruzzese J.L., Lee J.E., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15 (1997) 928-937
23. Mehta V.K., Fisher G., Ford J.A., et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 5 (2001) 27-35
24. Barreiro C.J., Lillemoe K.D., Koniaris L.G., et al. Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?. J Gastrointest Surg 6 (2002) 75-81
25. Cirillo Jr. R.L., and Koniaris L.G. Detecting blunt pancreatic injuries. J Gastrointest Surg 6 (2002) 587-598
26. Lygidakis N.J., Sgourakis G., Georgia D., Valchos L., and Raptis S. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: A prospective randomized study. Ann Surg 236 (2002) 806-813
27. Nukui Y., Picozzi V.J., and Traverso L.W. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179 (2000) 367-371
28. Picozzi V.J., Kozarek R.A., and Traverso L.W. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185 (2003) 476-480